Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2024 as against Rs 19.80 crore during the previous quarter ended September 2023. Sales rose 12.04% to Rs 222.70 crore in the quarter ended September 2024 as against Rs 198.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales222.70198.76 12 OPM %13.6211.73 - PBDT34.5327.86 24 PBT25.9020.02 29 NP27.2419.80 38 Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against Rs 9.40 crore during the previous quarter ended June 2023. Sales rose 33.62% to Rs 244.41 crore in the quarter ended June 2024 as against Rs 182.92 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales244.41182.92 34 OPM %13.2912.10 - PBDT36.5618.48 98 PBT28.1210.78 161 NP29.359.40 212 Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live News

Orchid Pharma announced that the Annual General Meeting (AGM) of the company will be held on 21 August 2024.Powered by Capital Market - Live News